1-3 of 3
Meaghan D. Rollins, BHK
Close
Sort by
Journal Articles

Improved Survival in Red Blood Cell Transfusion Dependent Patients with Primary Myelofibrosis (PMF) Receiving Iron Chelation Therapy.

Heather Leitch, MD, PhD, Hatoon Ezzat, MBBS, Meaghan D Rollins, BHK, Trisha A Goodman, BHK, Chantal S Leger, MD, Dominic HC Wong, BSc, Khaled M Ramadan, MB, Lynda M Foltz, MD, Linda M Vickars, MD
Journal: Blood
Blood (2008) 112 (11): 1748.
https://doi.org/10.1182/blood.V112.11.1748.1748
Published: 2008
Journal Articles

Improved Leukemia-Free and Overall Survival in Patients with Myelodysplastic Syndrome Receiving Iron Chelation Therapy: A Subgroup Analysis.

Heather A. Leitch, MD, PhD, Dominic H.C. Wong, Chantal S. Leger, MD, Khaled M. Ramadan, MD, Meaghan D. Rollins, BHK, Michael J. Barnett, MB, Trisha A. Goodman, BHK, Karen K. Wong, Paul F. Galbraith, MD, Linda M. Vickars, MD
Journal: Blood
Blood (2007) 110 (11): 1469.
https://doi.org/10.1182/blood.V110.11.1469.1469
Published: 2007
Journal Articles

Transfusion Dependence in Patients with Primary Myelofibrosis Has a Negative Impact on Survival Independent of Decreased Myelopoiesis.

Heather A. Leitch, MD, PhD, Hatoon Ezzat, MD, Meaghan D. Rollins, BHK, Dominic H.C. Wong, Chantal S. Leger, MD, Khaled M. Ramadan, MD, Michael J. Barnett, MB, Linda M. Vickars, MD
Journal: Blood
Blood (2007) 110 (11): 4653.
https://doi.org/10.1182/blood.V110.11.4653.4653
Published: 2007